39 completed, 6 terminated, 1 withdrawn. 46 Phase 2, 20 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 46 | Completed 39, Terminated 6, Withdrawn 1 |
| Phase 1 | 20 | Completed 17, Terminated 2, Withdrawn 1 |
Follow Adult Gliosarcoma: new trials by email Literature Review of Adult Gliosarcoma trials Research Report on Adult Gliosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients MSC11FCD - Glioblastoma, Adult Gliosarcoma | Phase 1 / Phase 2 | Completed | CHA University | 10 | 2020-06-24 | 2023-01-18 |
| EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma EGFRBi-Armed Autologous T Cells, Laboratory Biomarker Analysis - Adult Brain Glioblastoma, Adult Gliosarcoma | Phase 1 / Phase 2 | Withdrawn | Barbara Ann Karmanos Cancer Institute | 2015-08-01 | 2016-02-15 | |
| Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma radiation therapy, temozolomide, plerixafor - Adult Ependymoblastoma, Adult Giant Cell Glioblastoma | Phase 1 / Phase 2 | Completed | Lawrence Recht | 30 | 2014-11-01 | 2018-10-23 |
| NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma Bevacizumab, NovoTTF-l00A, Quality of Life Assessment - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | Case Comprehensive Cancer Center | 25 | 2013-09-18 | 2025-02-17 |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy 18F-fludeoxyglucose (18F-FDG), 18F-FPPRGD2 - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | Sanjiv Sam Gambhir | 25 | 2013-03-04 | 2019-10-03 |
| Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma dovitinib, laboratory biomarker analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | Manmeet Ahluwalia, MD | 33 | 2012-12-20 | 2017-12-12 |
| Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma bevacizumab, radiation therapy - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | Radiation Therapy Oncology Group | 182 | 2012-12-20 | 2022-12-29 |
| Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme Anti-Endoglin Chimeric Monoclonal Antibody TRC105, Bevacizumab, Laboratory Biomarker Analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 116 | 2012-11-01 | 2018-05-23 |
| Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme aminolevulinic acid, therapeutic conventional surgery - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Terminated | Michael Vogelbaum, MD, PhD | 8 | 2012-05-01 | 2018-07-31 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma gamma-secretase/Notch signalling pathway inhibitor RO4929097, therapeutic conventional surgery, pharmacological study - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 47 | 2010-12-01 | 2017-05-03 |
| RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma gamma-secretase/Notch signalling pathway inhibitor RO4929097, bevacizumab, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 13 | 2010-12-01 | 2015-12-14 |
| Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma 3-Dimensional Conformal Radiation Therapy, Cediranib Maleate, Intensity-Modulated Radiation Therapy - Adult Glioblastoma, Adult Gliosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 261 | 2010-02-26 | 2022-07-26 |
| GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery vismodegib, therapeutic conventional surgery, laboratory biomarker analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | National Cancer Institute (NCI) | 44 | 2010-02-01 | 2017-08-16 |
| Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma Laboratory Biomarker Analysis, Perifosine, Temsirolimus - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 36 | 2010-01-27 | 2021-07-19 |
| MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme FMISO, MRI, PET - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | National Cancer Institute (NCI) | 50 | 2009-08-24 | 2019-04-08 |
| Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme 3-Dimensional Conformal Radiation Therapy, Cognitive Assessment, Laboratory Biomarker Analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 125 | 2009-07-10 | 2022-08-04 |
| Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma Bendamustine Hydrochloride, Quality-of-Life Assessment - Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 2 | Completed | University of Washington | 45 | 2008-10-01 | 2017-07-07 |
| Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme vorinostat, therapeutic conventional surgery, bortezomib - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | National Cancer Institute (NCI) | 44 | 2008-07-01 | 2014-05-14 |
| Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Cediranib Maleate, Diffusion Tensor Imaging, Diffusion Weighted Imaging - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 46 | 2008-04-01 | 2023-06-06 |
| Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme R-(-)-gossypol acetic acid, laboratory biomarker analysis - Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 2 | Completed | National Cancer Institute (NCI) | 56 | 2008-01-01 | 2017-08-11 |
Showing 20 of 46. Sign in to see all of them.
Gliosarcoma (46) · Glioblastoma (45) · Brain Neoplasms (32) · Astrocytoma (10) · Oligodendroglioma (9) · Glioma (5) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Colonic Neoplasms (1) · Esthesioneuroblastoma, Olfactory (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1)
Neoplasms (46) · Neoplasms by Histologic Type (46) · Neoplasms, Glandular and Epithelial (46) · Neoplasms, Nerve Tissue (46) · Neoplasms, Neuroepithelial (46) · Neuroectodermal Tumors (46) · Neoplasms, Germ Cell and Embryonal (45) · Glioma (41) · Astrocytoma (35) · Brain Diseases (33) · Central Nervous System Diseases (33) · Neoplasms by Site (33) · Nervous System Diseases (33) · Nervous System Neoplasms (33) · Central Nervous System Neoplasms (32)
Temozolomide (8) · Radiotherapy (6) · Bevacizumab (5) · Erlotinib Hydrochloride (5) · Radiation (5) · Radiotherapy, Conformal (5) · Sirolimus (5) · temsirolimus (5) · Radiotherapy, Intensity-Modulated (3) · Sorafenib (3) · Vorinostat (3) · cediranib (3) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (2) · Cilengitide (2) · Disulfides (2)
National Cancer Institute (NCI) (37) · Barbara Ann Karmanos Cancer Institute (1) · CHA University (1) · Case Comprehensive Cancer Center (1) · Lawrence Recht (1) · Manmeet Ahluwalia, MD (1) · Michael Vogelbaum, MD, PhD (1) · Radiation Therapy Oncology Group (1) · Sanjiv Sam Gambhir (1) · University of Washington (1)
United States (44) · Canada (1) · Saudi Arabia (1) · South Korea (1)
Evanthia Galanis (5) · David Peereboom, MD (3) · Howard Fine, MD (2) · Mark Gilbert (2) · Tracy Batchelor (2) · Adam P. Dicker, MD, PhD (1) · Andrew Lassman (1) · Arnab Chakravarti (1) · Charles Nock, MD (1) · Christina Tsien (1) · David Brachman (1) · David Peereboom (1) · Edward Pan, MD (1) · Elizabeth Gerstner (1) · Elizabeth R Gerstner, MD (1)
PMID 25113840, PMID 18955445, PMID 20200024, PMID 20458050, PMID 21377994, PMID 21632852, PMID 22517399, PMID 23328813, PMID 24309981, PMID 24470557, PMID 25758746, PMID 25832688, PMID 25965900, PMID 26062933, PMID 26611425, PMID 27185374, PMID 29902200, PMID 30850872, PMID 31386061, PMID 33842889, PMID 36260832, PMID 38197800
U10CA025224 (8), U01CA062475 (7), U01CA062399 (6), U10CA021661 (6), U01CA137443 (5), U10CA180821 (3), U10CA180868 (2), N01CM62203 (1), N01CM62206 (1), N01CM62207 (1), P30CA006516 (1), P30CA008748 (1), P30CA015704 (1), P30CA016058 (1), P30CA022453 (1)